JPH11155958A - Medicinal liquid injecting port - Google Patents
Medicinal liquid injecting portInfo
- Publication number
- JPH11155958A JPH11155958A JP32596397A JP32596397A JPH11155958A JP H11155958 A JPH11155958 A JP H11155958A JP 32596397 A JP32596397 A JP 32596397A JP 32596397 A JP32596397 A JP 32596397A JP H11155958 A JPH11155958 A JP H11155958A
- Authority
- JP
- Japan
- Prior art keywords
- port
- main body
- connector
- drug solution
- internal space
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 29
- 239000003814 drug Substances 0.000 claims abstract description 21
- 229940079593 drug Drugs 0.000 claims abstract description 21
- 239000000463 material Substances 0.000 claims abstract description 14
- 230000001681 protective effect Effects 0.000 claims abstract description 12
- 230000002093 peripheral effect Effects 0.000 claims abstract description 6
- 239000000243 solution Substances 0.000 claims description 26
- 239000000126 substance Substances 0.000 claims description 23
- 238000002347 injection Methods 0.000 claims description 20
- 239000007924 injection Substances 0.000 claims description 20
- 239000007779 soft material Substances 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 5
- 230000008961 swelling Effects 0.000 claims 1
- 238000000034 method Methods 0.000 abstract description 3
- 238000001802 infusion Methods 0.000 description 6
- 229920005989 resin Polymers 0.000 description 5
- 239000011347 resin Substances 0.000 description 5
- 239000002246 antineoplastic agent Substances 0.000 description 4
- 229940041181 antineoplastic drug Drugs 0.000 description 4
- 238000007920 subcutaneous administration Methods 0.000 description 3
- 206010072170 Skin wound Diseases 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 238000002512 chemotherapy Methods 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000008155 medical solution Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 229920005749 polyurethane resin Polymers 0.000 description 2
- 229920002379 silicone rubber Polymers 0.000 description 2
- 239000004945 silicone rubber Substances 0.000 description 2
- 229910001220 stainless steel Inorganic materials 0.000 description 2
- 239000010935 stainless steel Substances 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 208000035004 Device kink Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 229930182556 Polyacetal Natural products 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- BZHJMEDXRYGGRV-UHFFFAOYSA-N Vinyl chloride Chemical compound ClC=C BZHJMEDXRYGGRV-UHFFFAOYSA-N 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 238000005452 bending Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000001951 dura mater Anatomy 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229920001971 elastomer Polymers 0.000 description 1
- 239000007943 implant Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000001361 intraarterial administration Methods 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 229920003049 isoprene rubber Polymers 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000002559 palpation Methods 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920006324 polyoxymethylene Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 238000007910 systemic administration Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Landscapes
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、進行癌患者の化学
療法における抗癌剤の動脈内注入、栄養補給のための静
脈注入、鎮痛のための髄硬膜等への鎮痛剤の投与、糖尿
病患者へのインシュリン投与等の如く、患者の体内の特
定箇所に長期間継続して、定期的に薬液を注入するため
の、皮下埋め込み可能な薬液注入システムに関するもの
である。TECHNICAL FIELD The present invention relates to an intraarterial infusion of an anticancer drug in chemotherapy for an advanced cancer patient, intravenous infusion for nutritional supplementation, administration of an analgesic to the dura mater for analgesia, and to a diabetic patient. The present invention relates to a medicinal solution injection system that can be implanted subcutaneously for continuously and periodically injecting a medicinal solution into a specific part of a patient's body for a long period of time, such as insulin administration.
【0002】[0002]
【従来の技術】切除不能な悪性腫瘍に対しては、抗癌剤
投与による化学療法が行われているが、全身投与法では
副作用を生じるため、選択的投与法としてカテーテル先
端を腫瘍局所へ通じる動脈上流に留置し、端末を抗癌剤
注入口として体外に露出させたままにするか、或は抗癌
剤投与の都度カテーテルを再挿入していた。(動注療
法)また、高カロリー輸液の持続注入の場合にも、カテ
ーテル先端を中心静脈内に留置し、端末を輸液注入口と
して体外に露出させていた。(IVH)2. Description of the Related Art Chemotherapy is administered to unresectable malignant tumors by administering anticancer drugs. However, systemic administration causes side effects. And the terminal was left exposed outside the body as an anticancer drug injection port, or the catheter was reinserted each time the anticancer drug was administered. (Arterial Infusion Therapy) Also, in the case of continuous infusion of high-calorie infusion, the tip of the catheter was placed in the central vein and the terminal was exposed outside the body as an infusion inlet. (IVH)
【0003】このためカテーテルを挿入した皮膚創部か
らの感染の防止は懸案課題であるが、一方皮膚創部を常
に清潔に保つことは実生活上は極めて困難であり、かつ
患者の自由な行動や入浴等にも制約があり、社会復帰に
大きな妨げとなっていた。このような問題の解決手段と
して、体内に長期間留置した状態で使用可能な皮下埋込
型のカテーテル組立体が開発されている。このカテーテ
ル組立体とは薬液を貯留するための内部空間と、この内
部空間に連通する円柱形の弾性体を圧縮装着した薬液注
入口、およびコネクターが付設された薬液流出路を有す
るポート本体と、薬液注入用のルーメンが形成されたカ
テーテルとを、前記流出路にルーメンが連通するように
前記コネクターにカテーテルを接続し、更にカテーテル
の固定及びキンク(折れ曲がり)防止のための保護ロッ
クをポート本体に嵌合させたものである。[0003] For this reason, prevention of infection from the skin wound where a catheter is inserted is a matter of concern, but keeping the skin wound clean at all times is extremely difficult in real life, and the patient's free behavior and bathing are difficult. There were also restrictions on this, and this was a major obstacle to rehabilitation. As a solution to such a problem, a subcutaneously implantable catheter assembly that can be used while being left in the body for a long time has been developed. The catheter assembly has an internal space for storing a drug solution, a drug solution inlet compressed and mounted with a cylindrical elastic body communicating with the internal space, and a port body having a drug solution outflow passage provided with a connector, A catheter formed with a lumen for injecting a drug solution is connected to the connector so that the lumen communicates with the outflow passage. Further, a protective lock for fixing the catheter and preventing kink (bending) is provided on the port body. They are fitted.
【0004】本皮下埋込型カテーテル組立体は、カテー
テルを目的の血管内等まで挿入し、薬液注入ポートを皮
下組織に固定した状態で留置される。そして、薬液を注
入する際は、皮膚の上から触診により薬液注入ポートの
薬液注入口を確認し、薬液注入口の弾性体を注射針にて
穿刺することにより薬液をポート本体内に送り込み、カ
テーテルを介して目的の血管内等へ薬液を注入する。The subcutaneous implantable catheter assembly is placed in a state where a catheter is inserted into a target blood vessel or the like and a drug solution injection port is fixed to a subcutaneous tissue. Then, when injecting the drug solution, the drug solution inlet port of the drug solution injection port is confirmed by palpation from above the skin, and the drug solution is sent into the port body by puncturing the elastic body of the drug solution inlet port with a syringe needle. A drug solution is injected into a target blood vessel or the like via the.
【0005】しかし、従来品はポート本体外周にコネク
ターが付設しており、ネジ嵌合等により接続固定される
保護ロックは、コネクター先端部でのカテーテルのキン
クを防ぐためコネクター先端よりも更に突出するように
設計されている。従って本皮下埋込型カテーテル組立体
を皮下に埋め込む場合はポート本体外周分の埋込スペー
スでは足りず、カテーテルの鉛直線上に保護ロックを含
めたスペース分の深い切開を施す必要があり、患者の負
担が大きいだけでなく、術者は薬液注入口を確認しにく
く、またポート本体と保護ロックを含めた直線が長い
(硬質部分が長い)ほど、患者の動きに対して追随でき
ずにカテーテルキンク等の種々の事故が起きる可能性が
大きかった。However, in the conventional product, a connector is attached to the outer periphery of the port body, and the protective lock connected and fixed by screw fitting or the like further projects beyond the connector tip in order to prevent the catheter from kinking at the connector tip. It is designed to be. Therefore, when the subcutaneous implantable catheter assembly is implanted subcutaneously, the implant space around the outer periphery of the port body is not enough, and it is necessary to make a deep incision on the vertical line of the catheter including the space including the protective lock. Not only is the burden heavy, but it is difficult for the surgeon to confirm the liquid inlet, and the longer the straight line (the longer the hard part) including the port body and the protective lock, the more difficult it is for the patient to follow the movement of the patient, and There is a high possibility that various accidents such as will occur.
【0006】[0006]
【発明が解決しようとする課題】本発明は、従来の技術
におけるカテーテルキンク等の問題点の軽減を図ること
を目的とするもので、ポート本体および保護ロックを嵌
合させた際の外周を軟質材で覆うことにより硬質部分最
大長が更に短くなり患者にとって低侵襲かつ安全な薬液
注入ポートを提供するものである。SUMMARY OF THE INVENTION An object of the present invention is to reduce problems such as catheter kinks in the prior art, and to provide a soft outer periphery when a port body and a protective lock are fitted. The covering with the material further shortens the maximum length of the rigid portion, and provides a less invasive and safe liquid injection port for the patient.
【0007】[0007]
【課題を解決するための手段】即ち本発明は、薬液を貯
留するための内部空間と、この内部空間に連通する薬液
注入口と、この薬液注入口を封止する弾性体と、前記内
部空間に連通する薬液流出路とを有し、該薬液流出路先
にコネクターを備えるポート本体と、カテーテル接続の
際の保護ロックを組み合わせた薬液注入ポートであっ
て、前記薬液流出路方向のみポート本体が凹部をなし、
該凹部内に前記コネクターが設置されており、前記保護
ロックをポート本体の凹部に嵌合させたときの外観がポ
ート本体外周とほぼ一体化する形状であり、更にその
際、表面に現れる外周部分は全てショアーA硬度30度
から70度の範囲の硬度の軟質材で覆われており、薬液
を貯留するための内部空間を形成する針受部、薬液注入
口を封止する弾性体を圧縮固定する保持部およびコネク
ターが硬質材であることを特徴とする薬液注入ポートで
ある。That is, the present invention provides an internal space for storing a chemical solution, a chemical liquid inlet communicating with the internal space, an elastic body for sealing the chemical liquid inlet, and the internal space. A port body provided with a connector at the tip of the drug solution outflow path, and a drug injection port combining a protection lock at the time of catheter connection, wherein the port body only in the drug solution outflow direction. Make a recess,
The connector is installed in the recess, and the appearance when the protection lock is fitted into the recess of the port body is substantially integrated with the outer periphery of the port body, and at that time, the outer peripheral portion that appears on the surface Are all covered with a soft material with a hardness in the range of 30 to 70 degrees Shore A hardness, and compressively fix the needle receiving part that forms the internal space for storing the chemical solution and the elastic body that seals the chemical solution inlet The chemical liquid injection port is characterized in that the holding portion and the connector are hard materials.
【0008】[0008]
【発明の実施の形態】以下、図面をもとに本発明につい
て詳細に説明する。図1は本発明による薬液注入ポート
の概略図で、図2は一実施例を示す平面図(a)及び側
断面図(b)である。図1、2の如く本発明の薬液注入
ポートはポート本体(1)と保護ロック(11)からな
り、ポート本体(1)は薬液を貯留するための内部空間
(4)を有し、この上部に弾性体(3)を装着した薬液
注入口(2)を有し、更に一半径方向に薬液流出路
(5)が設けてありその方向のポート本体(1)は外周
に対して凹部(9)をなし、凹部(9)の中央にカテー
テル(21)を接続するためのコネクター(6)が付設
されている。すなわちポート本体(1)を上面から見た
外観は円盤形状の一部分が欠けた形状である。また側面
から見た外観は上下に膨らんだ形状をなしている。な
お、薬液流出路(5)は必要により薬液を流出させる
が、逆流を防ぐための一方弁を設けることも好ましい実
施例の一つである。DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS The present invention will be described below in detail with reference to the drawings. FIG. 1 is a schematic view of a liquid injection port according to the present invention, and FIG. 2 is a plan view (a) and a side sectional view (b) showing one embodiment. As shown in FIGS. 1 and 2, the liquid injection port of the present invention comprises a port main body (1) and a protection lock (11). The port main body (1) has an internal space (4) for storing a chemical liquid. A chemical liquid inlet (2) having an elastic body (3) mounted thereon, and a chemical liquid outflow passage (5) provided in one radial direction. The port body (1) in that direction has a concave portion (9) with respect to the outer periphery. ), And a connector (6) for connecting a catheter (21) is provided at the center of the concave portion (9). That is, the external appearance of the port body (1) viewed from above is a shape in which a part of the disk shape is missing. In addition, the appearance seen from the side has a shape bulging up and down. In addition, although the chemical | medical solution outflow path (5) makes a chemical | medical solution flow out as needed, it is one of the preferable embodiments to provide a one-way valve for preventing backflow.
【0009】ポート本体(1)の材質としては軟質材と
硬質材の組み合わせから構成され、薬液を貯留するため
の内部空間(4)を形成する針受部(7)は注射針が貫
通しないよう又注射針の針先が内部空間(4)に完全に
達したことを触感により知らせるため、また薬液注入口
(2)を封止する弾性体(3)を圧縮固定するための保
持部(8)は弾性体(3)に強い圧縮力を加えるため、
ポート本体(1)の内部に位置する針受部(7)と保持
部(8)の2部分は硬質材でできており、それ以外のポ
ート本体(1)の外周部分はショアーA硬度30度から
70度の範囲の硬度の軟質材よりなっている。各々の材
質について具体例を挙げると、生体適合性の優れている
ことが必要で、例えば、硬質材ではポリエーテルスルフ
ォン樹脂、ポリアセタール樹脂等の樹脂やステンレス、
チタニウム等の金属であり、また軟質材ではポリウレタ
ン樹脂、シリコーンゴム等の樹脂が考えられる。The material of the port body (1) is made of a combination of a soft material and a hard material, and a needle receiving portion (7) forming an internal space (4) for storing a chemical solution is provided so that an injection needle does not penetrate. A holding part (8) for notifying by a tactile sensation that the tip of the injection needle has completely reached the internal space (4), and for compressing and fixing an elastic body (3) for sealing the chemical liquid inlet (2). ) Applies a strong compressive force to the elastic body (3),
The needle receiving part (7) and the holding part (8) located inside the port body (1) are made of a hard material, and the outer peripheral part of the other port body (1) is 30 degrees Shore A hardness. And a soft material having a hardness ranging from 70 degrees to 70 degrees. To give a specific example of each material, it is necessary to have excellent biocompatibility, for example, a hard material such as polyether sulfone resin, resin such as polyacetal resin and stainless steel,
It is a metal such as titanium, and a soft material is a resin such as a polyurethane resin or a silicone rubber.
【0010】次いで、弾性体(3)の材質としては、自
己封止性を有する弾性状物質であり、例えばシリコーン
ゴム、イソプレンゴム、ラテックス等のゴムが考えられ
るが軟質の塩化ビニル樹脂やポリウレタン樹脂でも針刺
し耐久性および生体適合性に優れれば使用可能である。
更にコネクター(6)の材質としては、強度的にステン
レスやチタニウム等の金属が望ましいが限定されるもの
ではない。ポート本体(1)は以上の構成部材をインサ
ート成形や接着および溶着等により組み立てられる。次
に保護ロック(11)について説明すると、外観は前記
ポート本体(1)の円盤形状の欠けた部分に等しく、中
央にカテーテル(21)を挿入するための嵌合穴(1
2)があり、材質としては前記ポート(1)と同様であ
り、後端部のポート本体(1)との嵌合部はカテーテル
末端を保持固定するために硬質材が望ましく、ポート本
体(1)と嵌合させた際、表面に位置する外周部分は軟
質材よりなっている。Next, the material of the elastic body (3) is an elastic substance having a self-sealing property, for example, rubber such as silicone rubber, isoprene rubber, latex, etc., but soft vinyl chloride resin or polyurethane resin. However, it can be used if it has excellent needle sticking durability and biocompatibility.
Further, the material of the connector (6) is preferably a metal such as stainless steel or titanium from the viewpoint of strength, but is not limited. The port body (1) is assembled by insert molding, bonding, welding and the like of the above-mentioned constituent members. Next, the protective lock (11) will be described. The appearance is the same as the disc-shaped missing portion of the port body (1), and the fitting hole (1) for inserting the catheter (21) in the center is provided.
2), the material is the same as that of the port (1), and the fitting portion of the rear end portion with the port body (1) is desirably a hard material for holding and fixing the catheter end. ), The outer peripheral portion located on the surface is made of a soft material.
【0011】次に本発明による薬液注入ポートの使用方
法について説明する。組立方法は図1に示すように、予
め保護ロック(11)に通したカテーテル(21)をポ
ート本体(1)のコネクター(6)に挿入接続し、更に
保護ロック(11)をカテーテル(21)上をスライド
させポート本体(1)に嵌合固定させる。このとき本発
明の薬液注入ポートは保護ロック(11)が突出するこ
となく正に円盤形状をなし、更に側面から見た形状が上
下に膨らんだ形状であるため皮下に埋設させた際、体組
織との死腔(隙間)が出来にくい形状をなしている。Next, a method of using the liquid injection port according to the present invention will be described. As shown in FIG. 1, the assembling method is as follows. A catheter (21) previously passed through a protection lock (11) is inserted and connected to a connector (6) of a port body (1), and further, the protection lock (11) is connected to a catheter (21). Slide up to fit and secure to port body (1). At this time, the liquid injection port of the present invention has a disk shape without the protection lock (11) protruding, and further has a body structure when subcutaneously buried under a subcutaneous shape when viewed from the side because the shape is swollen up and down. It is difficult to form a dead space (gap).
【0012】[0012]
【発明の効果】以上に述べた如く、本発明による薬液注
入ポートはポート本体および保護ロックを嵌合させた
際、突出部分のない流線型の円盤形状をなし更に外周を
軟質材で覆うことにより硬質部分最大長が短くなり、患
者にとって低侵襲かつ安全な用具として極めて有用であ
る。As described above, when the liquid injection port according to the present invention is fitted with the port main body and the protection lock, the liquid injection port has a streamlined disk shape with no protruding portion, and the outer periphery is covered with a soft material so as to be hard. Since the partial maximum length is short, it is extremely useful as a minimally invasive and safe tool for patients.
【図1】本発明の一実施例となる薬液注入ポートを示す
斜視図である。FIG. 1 is a perspective view showing a chemical injection port according to an embodiment of the present invention.
【図2】本発明の一実施例を示す図で、(a)は平面
図、(b)は側断面図である。FIG. 2 is a view showing one embodiment of the present invention, wherein (a) is a plan view and (b) is a side sectional view.
1 ポート本体 11 保護ロック 2 薬液注入口 12 嵌合穴 3 弾性体 21 カテーテル 4 内部空間 5 薬液流出路 6 コネクター 7 針受部 8 弾性体保持部 9 凹部 DESCRIPTION OF SYMBOLS 1 Port main body 11 Protective lock 2 Chemical liquid inlet 12 Fitting hole 3 Elastic body 21 Catheter 4 Internal space 5 Chemical liquid outflow path 6 Connector 7 Needle receiving part 8 Elastic body holding part 9 Recess
Claims (3)
内部空間に連通する薬液注入口と、この薬液注入口を封
止する弾性体と、前記内部空間に連通する薬液流出路と
を有し、該薬液流出路先にコネクターを備えるポート本
体と、カテーテル接続の際の保護ロックを組み合わせた
薬液注入ポートであって、前記薬液流出路方向のみポー
ト本体が凹部をなし、該凹部内に前記コネクターが設置
されており、前記保護ロックをポート本体の凹部に嵌合
させたときの外観がポート本体外周とほぼ一体化する形
状であり、更にその際、表面に現れる外周部分は全てシ
ョアーA硬度30度から70度の範囲の硬度の軟質材で
覆われていることを特徴とする薬液注入ポート。1. An internal space for storing a chemical solution, a chemical liquid inlet communicating with the internal space, an elastic body sealing the chemical liquid inlet, and a chemical liquid outflow passage communicating with the internal space. A port body provided with a connector at the tip of the drug solution outflow path, and a drug solution injection port combining a protection lock at the time of catheter connection, wherein the port body forms a recess only in the direction of the drug solution outflow path, and the recess is formed in the recess. A connector is installed, and the appearance when the protective lock is fitted into the concave portion of the port body is substantially integrated with the outer periphery of the port body, and at this time, the outer peripheral portion that appears on the surface is entirely Shore A hardness. A chemical injection port, which is covered with a soft material having a hardness in a range from 30 degrees to 70 degrees.
めの内部空間を形成する針受部、薬液注入口を封止する
弾性体を圧縮固定する保持部およびコネクターが硬質材
である請求項1記載の薬液注入ポート。2. The port body, wherein a needle receiving portion forming an internal space for storing a drug solution, a holding portion for compressing and fixing an elastic body sealing a drug solution inlet, and a connector are hard materials. Liquid injection port.
きに、側面から見た形状が上下に膨らんだ形状をなして
いる請求項1又は2記載の薬液注入ポート。3. The chemical liquid injection port according to claim 1, wherein when the port body and the protection lock are fitted together, the shape as viewed from the side has a vertically swelling shape.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32596397A JPH11155958A (en) | 1997-11-27 | 1997-11-27 | Medicinal liquid injecting port |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP32596397A JPH11155958A (en) | 1997-11-27 | 1997-11-27 | Medicinal liquid injecting port |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH11155958A true JPH11155958A (en) | 1999-06-15 |
Family
ID=18182558
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP32596397A Pending JPH11155958A (en) | 1997-11-27 | 1997-11-27 | Medicinal liquid injecting port |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH11155958A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2024519068A (en) * | 2021-05-20 | 2024-05-08 | バード・ペリフェラル・バスキュラー・インコーポレーテッド | Silicone low profile port with rigid base plate and stem |
-
1997
- 1997-11-27 JP JP32596397A patent/JPH11155958A/en active Pending
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2024519068A (en) * | 2021-05-20 | 2024-05-08 | バード・ペリフェラル・バスキュラー・インコーポレーテッド | Silicone low profile port with rigid base plate and stem |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6290677B1 (en) | Medicinal liquid injection port | |
US4464178A (en) | Method and apparatus for administration of fluids | |
US4559033A (en) | Apparatus and methods for minimizing peritoneal injection catheter obstruction | |
US7524300B2 (en) | Infusion device | |
US4581020A (en) | Medication delivery device and system for percutaneous administration of medication | |
EP0551017B1 (en) | Implantable infusion device | |
US20030032947A1 (en) | Osmotic pump drug delivery systems and methods | |
US20050209573A1 (en) | Method and apparatus for percutaneously accessing a pressure activated implanted port | |
JPH10127777A (en) | Pharmaceutical liquid injecting port | |
JP2000079168A (en) | Liquid medicine pouring port | |
US11504516B2 (en) | Port catheter | |
JP3169547B2 (en) | Chemical injection port | |
JPH11155958A (en) | Medicinal liquid injecting port | |
JPH08107934A (en) | Cap for subcutaneous embedment type medicinal liquid injecting port sleeve | |
JP3248839B2 (en) | Chemical injection port | |
JPH1147278A (en) | Medicinal liquid injection port | |
JP3137360B2 (en) | Chemical injection port | |
JP3447215B2 (en) | Chemical injection port | |
JPH03275075A (en) | Liquid medicine injection port | |
JPH0613849U (en) | Chemical injection port | |
CA1234029A (en) | Peritoneal injection catheter apparatus and methods | |
JP2000005322A (en) | Medical liquid injection port | |
JP2000316985A (en) | Subcutaneous implanting typed injection port | |
JPH067867B2 (en) | Implantable chemical injection port |